Manuel Neuberger
Overview
Explore the profile of Manuel Neuberger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Steffens F, Wessels F, Hetjens S, Carl N, Nitschke K, Uysal D, et al.
Int Urol Nephrol
. 2025 Jan;
PMID: 39871032
Purpose: To identify prognostic factors for overall survival (OS) and develop a prognostic score in patients receiving docetaxel in metastatic castration-resistant prostate cancer (mCRPC). Methods: Retrospective analysis was conducted on...
2.
Xu J, Koch J, Schmidt C, Nientiedt M, Neuberger M, Erben P, et al.
Exp Mol Med
. 2024 Dec;
57(1):118-130.
PMID: 39741187
Bladder cancer poses significant clinical challenges due to its high metastatic potential and poor prognosis, especially when it progresses to muscle-invasive stages. Here, we show that the mA reader YTHDC1...
3.
Wessels F, Bussoff I, Adam S, Kowalewski K, Neuberger M, Nuhn P, et al.
Bladder Cancer
. 2024 Jul;
8(2):155-163.
PMID: 38993365
Background: Pre-operative risk assessment in radical cystectomy (RC) is an ongoing challenge especially in elderly patients. Objective: To evaluate the ability of comorbidity indices and their combination with clinical parameters...
4.
Sidoti Abate M, Menold H, Neuberger M, Kirchner M, Haney C, Nuhn P, et al.
BJU Int
. 2024 May;
134(3):434-441.
PMID: 38816992
Objectives: To comprehensively compare quality-of-life (QoL) outcomes between open partial nephrectomy (OPN) and robot-assisted PN (RAPN) from the randomised ROBOtic-assisted versus Conventional Open Partial nephrectomy (ROBOCOP) II trial, as QoL...
5.
Walach M, Nitschke K, Gross-Weege M, Grosshans J, Wildner L, Pause L, et al.
Urol Int
. 2024 Jan;
108(2):128-136.
PMID: 38224675
Introduction: The aim was to evaluate the prognostic value of altered Cyclin A2 (CCNA2) gene expression in upper tract urothelial carcinoma (UTUC) and to assess its predictive potential as a...
6.
Wieland V, Uysal D, Probst P, Grilli M, Haney C, Sidoti Abate M, et al.
Int J Surg Protoc
. 2023 Dec;
27(2):9-15.
PMID: 38045560
Background: Knowledge of current and ongoing studies is critical for identifying research gaps and enabling evidence-based decisions for individualized treatment. However, the increasing number of scientific publications poses challenges for...
7.
Koch J, Neuberger M, Schmidt-Dengler M, Xu J, Carneiro V, Ellinger J, et al.
iScience
. 2023 Aug;
26(8):107300.
PMID: 37554463
METTL3 is the major writer of N6-Methyladenosine (mA) and has been associated with controversial roles in cancer. This is best illustrated in urothelial carcinoma of the bladder (UCB), where METTL3...
8.
Neuberger M, Kowalewski K, Simon V, von Hardenberg J, Siegel F, Wessels F, et al.
Eur Urol Oncol
. 2023 Aug;
7(1):53-62.
PMID: 37543465
Background: Symptomatic lymphoceles (SLCs) after transperitoneal robotic-assisted radical prostatectomy with pelvic lymph node dissection (PLND) are common. Evidence from randomised controlled trials (RCTs) on the impact of peritoneal flaps (PFs)...
9.
A self-supervised vision transformer to predict survival from histopathology in renal cell carcinoma
Wessels F, Schmitt M, Krieghoff-Henning E, Nientiedt M, Waldbillig F, Neuberger M, et al.
World J Urol
. 2023 Jun;
41(8):2233-2241.
PMID: 37382622
Purpose: To develop and validate an interpretable deep learning model to predict overall and disease-specific survival (OS/DSS) in clear cell renal cell carcinoma (ccRCC). Methods: Digitised haematoxylin and eosin-stained slides...
10.
Haney C, Kowalewski K, Westhoff N, Holze S, Checcuci E, Neuberger M, et al.
Eur Urol Focus
. 2023 Jun;
9(6):930-937.
PMID: 37353415
Context: Robot-assisted radical prostatectomy (RARP) has largely replaced conventional laparoscopic radical prostatectomy (LRP) even though the costs are significantly higher. Justification for this change is the hope for better postoperative...